Akcea Therapeutics is biopharmaceutical company developing and marketing drugs globally to treat patients with rare and serious diseases. The company's TEGSEDI treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. The company is also focused on commercial preparations for WAYLIVRA in the European Union. WAYLIVRA is an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome, who are at risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. TEGSEDI, WAYLIVRA and its pipeline drugs are based on the company's antisense technology platform.

Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company has three platforms: its Oncology Innovation Platform, dedicated to the research and development of its proprietary drugs; its Commercial Platform, focused on the sales and marketing of its specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src Kinase inhibition, T-cell Receptor-engineered T-cells, and arginine deprivation therapy.

Capital Bancorp is a bank holding company. Through its subsidiary, Capital Bank, N.A. (the Bank), the company is principally engaged in the business of investing in commercial, real estate, and credit card loans and accepting deposits in Rockville, Columbia and North Bethesda, MD, Reston, VA, and the District of Columbia. The Bank operates three divisions: Commercial Banking, which provides commercial and industrial, commercial real estate and construction lending solutions; Church Street Mortgage, which originates conventional and government-guaranteed residential mortgage loans; and OpenSky?, which provides credit cards to under-banked populations and those looking to rebuild their credit scores.

FleetCor Technologies is provider of commercial payment solutions. The company's five primary product lines are Fuel, which provides fuel payment solutions to businesses and government entities who operate vehicle fleets, as well as to main oil companies;Lodging, which provides lodging payment solutions to employees who travel overnight for work purposes; Tolls, which provides an electronic toll and parking payments product; Corporate Payments, which include virtual cards, purchasing cards, travel and entertainment cards; and Gift, which provides gift card product management and processing services. Additionally, the company provides other payment products including fleet maintenance and employee benefits.

GameStop is a multichannel video game and licensed consumer products retailer. The company's products and services includes: New Video Game Hardware, which provides video game platforms from manufacturers; New Video Game Software, which provides new video game software for existing and certain prior generation consoles from manufacturers, including Sony, Nintendo and Microsoft; Video Game Accessories, which consist primarily of controllers, gaming headsets, virtual reality products, and memory cards; and Digital, which sells a variety of digital currency and has developed technology to sell downloadable content and full-game downloads in its stores and on its U.S. website.

KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The company's product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company has a portfolio of oral plasma kallikrein inhibitors and developed various drug candidates into clinical trials in order to create oral therapies for both HAE and DME. The company has initiated a clinical study of KVD900 as a therapy for acute HAE attacks. The company has also commenced a clinical trial of KVD001, its DME drug candidate.

Occidental Petroleum has three reporting segments: oil and gas, which explores for, develops and produces oil and condensate, natural gas liquids (NGL) and natural gas; chemical, which mainly manufactures and markets basic chemicals (chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates and calcium chloride) and vinyls (vinyl chloride monomer, polyvinyl chloride and ethylene); and marketing and midstream, which purchases, markets, gathers, processes, transports and stores oil, condensate, NGL, natural gas, carbon dioxide and power.

Provention Bio is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company's principal product candidates include: PRV-031 (teplizumab, anti-CD3 mAb) for the interception of type 1 diabetes; PRV-015 (anti-IL-15 mAb) for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 (oral CSF-1R inhibitor) for the treatment of Crohn's disease; PRV-300 (anti-TLR3 mAb) for the treatment of ulcerative colitis; and PRV-3279 (humanized anti-CD32B and CD79B bispecific) for the treatment of lupus.

Roadrunner Transportation Systems is an asset-right transportation and asset-light logistics service provider providing a suite of solutions under the Roadrunner, Active On-Demand and Ascent Global Logistics brands. The company has three segments: Truckload and Express Services, which provides air and ground expedite services, scheduled truckload services, intermodal services, temperature-controlled truckload services, and other truckload and logistics services; Less-than-Truckload (LTL), which involves the pickup, consolidation, linehaul, deconsolidation, and delivery of LTL shipments; and Ascent Global Logistics, which provides domestic freight management solutions.

Slack Technologies operates a business technology software platform that brings together people, applications, and data and sells its offering under a software-as-a-service model in the United States and internationally.

Ulta Beauty is a beauty retailer that provides cosmetics, fragrance, skin care products, hair care products, and salon services. The company's stores are primarily located in locations such as power centers. The company provides a range of services in all of its stores. The company's stores, website, and mobile applications provides more than 25,000 products from approximately 500 beauty brands across all categories and price points, including its own private label, the Ulta Beauty Collection. The company provides a portfolio across five primary categories: cosmetics; skincare, bath and fragrance; haircare products and styling tools; salon services; and other, which includes nail products and accessories.